ATC Group: J01CF02 Cloxacillin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J01CF02 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J01 Antibacterials for systemic use
3 J01C Beta-lactam antibacterials, penicillins
4 J01CF Beta-lactamase resistant penicillins
5 J01CF02 Cloxacillin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 2 g
PAREN - Parenteral 2 g

Active ingredients in J01CF02

Active Ingredient Description
Cloxacillin

Cloxacillin is a semi-synthetic beta-lactamase resistant penicillin with activity against gram-negative and gram-positive bacteria including beta-lactamase producing staphylococci. Cloxacillin acts by interfering with the formation of new bacterial cell wall by dividing organisms.

Related product monographs

Title Information Source Document Type  
MONOCLOX Powder for solution for injection or infusion Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicines in this ATC group

Cyprus (CY)

France (FR)

Hong Kong (HK)

Poland (PL)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.